Management of pregabalin use disorder: A case series

L. LANGLUME ; C. EIDEN ; S. ROY ; F. TARUFFI ; J. GAMBIER ; H. DONNADIEU-RIGOLE ; H. PEYRIÈRE | 2022
Dans Journal of Psychoactive Drugs (Vol.54, n°4, September-October 2022) Article : Périodique

Pregabalin is indicated for the treatment of partial epilepsy, generalized anxiety disorder, and neuropathic pain. The first reports on pregabalin use disorder have been published in Europe in 2010 and notified to the French Addictovigilance Net[...]

Plus d'info

Ajouter à la sélection

Lien externe